Skip to main content
Clinical Trials/NCT04736069
NCT04736069
Completed
Not Applicable

The Cost-effectiveness of Inpatient and Outpatient Physical Therapy Programs in Knee Osteoarthritis

Ufuk University0 sites60 target enrollmentMarch 1, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis, Knee
Sponsor
Ufuk University
Enrollment
60
Primary Endpoint
Quality of Life; Short-Form 36-General Health
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Knee osteoarthritis (OA) is a disease with significant levels of socioeconomic burden to the society. P The non-pharmacologic interventions in knee OA include weight loss, exercise, and physical therapy. In this study, we aimed to to compare the cost-effectiveness of inpatient and outpatient physical therapy programs in patients with knee osteoarthritis.

Detailed Description

Knee osteoarthritis (OA) is a major problem for society with a heavy economic burden. Especially in the elderly population, integrated rehabilitation programs are frequently used to improve patients' symptoms and quality of life. To estimate the costs and utility of the rehabilitation programs may help clinicians decide optimal treatment strategy with proper usage of resources. Therefore, we aimed to to compare the cost-effectiveness of inpatient and outpatient physical therapy programs in patients with knee osteoarthritis.The study included 52 patients with the diagnose of knee osteoarthritis. Patients were divided into two groups. Group 1 (n=30) received 21 sessions of inpatient physical therapy program including electrotherapy, superficial- deep heat applications and basic knee exercise program. Group 2 (n=22) received the same physical therapy program at outpatient clinic.

Registry
clinicaltrials.gov
Start Date
March 1, 2011
End Date
January 30, 2013
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ufuk University
Responsible Party
Principal Investigator
Principal Investigator

Nihan Cuzdan

Doctor

Ufuk University

Eligibility Criteria

Inclusion Criteria

  • Knee OA diagnosed patients based on American College of Rheumatology Criteria

Exclusion Criteria

  • visual disturbances
  • malignancy
  • inflammatory rheumatic diseases
  • pregnancy
  • advanced cardiovascular, kidney or liver pathologies
  • uncontrolled hypertension
  • patients who had injuries in their lower extremities
  • patients who underwent under total hip or knee prosthetic surgeries.

Outcomes

Primary Outcomes

Quality of Life; Short-Form 36-General Health

Time Frame: Change from Baseline Short-Form 36 scores at 6 months

Short-Form 36 (SF-36) which is composed of eight multi-item scales as bodily pain, physical functioning, social functioning, role-physical, role-emotional, vitality, general health, mental health. Each score of these scales ranging from 0 to 100; higher scores indicating higher QoL.

Median Total Cost Per Participant for Health Care

Time Frame: baseline-six months

median total expenses for health care at the end of the study

Pain; Visual Analog Scale (VAS)

Time Frame: Change from Baseline VAS scores at 6 months

Patients were requested to sign their pain level on a 10 cm horizontal line with terminal ends of 'no pain' and 'the worst pain'

Physical Function; Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index

Time Frame: Change from Baseline WOMAC scores at 6 months

WOMAC questionnaire includes five items for pain, two for stiffness, and 17 for functional limitation (score range 0-68). All the items are scored on a scale of 0-4, with higher scores indicating a higher level of symptoms or physical disability.

Fall Risk Assessment; Hendrich II Fall Risk Scale

Time Frame: Change from Baseline Hendrich II Fall Risk Scale at 6 months

The scale includes seven items. These items are confusion \& disorientation, depression, change in excretion, dizziness, gender, antiepileptic \& benzodiazepine use, and get up and walk test. The final score is the sum of these scores; (the score range is between 0-16; 16 is the highest possible score) Patients five or more scores on the scale are considered to be at high risk.

Similar Trials